全文获取类型
收费全文 | 217375篇 |
免费 | 29440篇 |
国内免费 | 7420篇 |
专业分类
耳鼻咽喉 | 1837篇 |
儿科学 | 1597篇 |
妇产科学 | 6488篇 |
基础医学 | 16098篇 |
口腔科学 | 2471篇 |
临床医学 | 17890篇 |
内科学 | 19750篇 |
皮肤病学 | 1399篇 |
神经病学 | 1480篇 |
特种医学 | 6357篇 |
外国民族医学 | 260篇 |
外科学 | 30789篇 |
综合类 | 28704篇 |
现状与发展 | 39篇 |
一般理论 | 3篇 |
预防医学 | 10761篇 |
眼科学 | 125篇 |
药学 | 14885篇 |
151篇 | |
中国医学 | 5846篇 |
肿瘤学 | 87305篇 |
出版年
2024年 | 702篇 |
2023年 | 4594篇 |
2022年 | 9010篇 |
2021年 | 11737篇 |
2020年 | 10943篇 |
2019年 | 9772篇 |
2018年 | 9390篇 |
2017年 | 9986篇 |
2016年 | 10749篇 |
2015年 | 12408篇 |
2014年 | 17993篇 |
2013年 | 17532篇 |
2012年 | 14284篇 |
2011年 | 14573篇 |
2010年 | 10694篇 |
2009年 | 10756篇 |
2008年 | 10939篇 |
2007年 | 10279篇 |
2006年 | 9094篇 |
2005年 | 7397篇 |
2004年 | 6133篇 |
2003年 | 5154篇 |
2002年 | 4317篇 |
2001年 | 3953篇 |
2000年 | 3225篇 |
1999年 | 2739篇 |
1998年 | 2318篇 |
1997年 | 2057篇 |
1996年 | 1679篇 |
1995年 | 1561篇 |
1994年 | 1299篇 |
1993年 | 995篇 |
1992年 | 869篇 |
1991年 | 784篇 |
1990年 | 589篇 |
1989年 | 550篇 |
1988年 | 462篇 |
1987年 | 397篇 |
1986年 | 322篇 |
1985年 | 408篇 |
1984年 | 338篇 |
1983年 | 230篇 |
1982年 | 241篇 |
1981年 | 206篇 |
1980年 | 186篇 |
1979年 | 121篇 |
1978年 | 84篇 |
1977年 | 62篇 |
1976年 | 58篇 |
1975年 | 33篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
131.
Melanoma is a deadly tumor, which in recent years has been successfully treated with immune checkpoint inhibitors as PD-1/PD-L1 and CTLA-4 inhibitors and targeted therapy as BRAF and MEK inhibitors. However, immunotherapy poses deleterious side effects and pursuit of new therapeutic targets is warranted. As knowledge of tumor immunology advances, such targets are being recognized. C-motif chemokine receptor-5 (CCR5) is a receptor found on immune cells whose effects impact the immune response both to induce inflammation and to activate suppressor cells causing an anti-inflammatory effect. CCR5 is well known as a target for HIV therapy where its blockade is efficient and safe, it is also known that its mutation CCR5delta32 is for the most part non-pathological to its carriers. In oncology, activation of the CCR5 receptor has been observed in high-stage disease and CCR5 blockade has been associated with an increased immune response. In this letter, we build up the rationale to utilize CCR5 as a therapeutic target for metastatic melanoma. 相似文献
132.
133.
134.
《Clinical oncology (Royal College of Radiologists (Great Britain))》2020,32(6):347-353
The current COVID-19 pandemic presents a substantial obstacle to cancer patient care. Data from China as well as risk models suppose that cancer patients, particularly those on active, immunosuppressive therapies are at higher risks of severe infection from the illness. In addition, staff illness and restructuring of services to deal with the crisis will inevitably place treatment capacities under significant strain. These guidelines aim to expand on those provided by NHS England regarding cancer care during the coronavirus pandemic by examining the known literature and provide guidance in managing patients with urothelial and rarer urinary tract cancers. In particular, they address the estimated risk and benefits of standard treatments and consider the alternatives in the current situation. As a result, it is recommended that this guidance will help form a framework for shared decision making with patients. Moreover, they do not advise a one-size-fits-all approach but recommend continual assessment of the situation with discussion within and between centres. 相似文献
135.
136.
Melatonin induces apoptosis of colorectal cancer cells through HDAC4 nuclear import mediated by CaMKII inactivation
下载免费PDF全文
![点击此处可从《Journal of pineal research》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Melatonin induces apoptosis in many different cancer cell lines, including colorectal cancer. However, the precise mechanisms involved remain largely unresolved. In this study, we provide evidence to reveal a new mechanism by which melatonin induces apoptosis of colorectal cancer LoVo cells. Melatonin at pharmacological concentrations significantly suppressed cell proliferation and induced apoptosis in a dose‐dependent manner. The observed apoptosis was accompanied by the melatonin‐induced dephosphorylation and nuclear import of histone deacetylase 4 (HDAC4). Pretreatment with a HDAC4‐specific siRNA effectively attenuated the melatonin‐induced apoptosis, indicating that nuclear localization of HDAC4 is required for melatonin‐induced apoptosis. Moreover, constitutively active Ca2+/calmodulin‐dependent protein kinase II alpha (CaMKIIα) abrogated the melatonin‐induced HDAC4 nuclear import and apoptosis of LoVo cells. Furthermore, melatonin decreased H3 acetylation on bcl‐2 promoter, leading to a reduction of bcl‐2 expression, whereas constitutively active CaMKIIα(T286D) or HDAC4‐specific siRNA abrogated the effect of melatonin. In conclusion, the present study provides evidence that melatonin‐induced apoptosis in colorectal cancer LoVo cells largely depends on the nuclear import of HDAC4 and subsequent H3 deacetylation via the inactivation of CaMKIIα. 相似文献
137.
Fur-Hsing Wen Jen-Shi Chen Wen-Chi Chou Wen-Cheng Chang Wen Chi Shen Chia-Hsun Hsieh Siew Tzuh Tang 《Journal of pain and symptom management》2019,57(1):64-72
Context
Family caregivers constitute a critical component of the end-of-life care system with considerable cost to themselves. However, the joint association of terminally ill cancer patients' symptom distress and functional impairment with caregivers' subjective caregiving burden, quality of life (QOL), and depressive symptoms remains unknown.Objectives/Methods
We used multivariate hierarchical linear modeling to simultaneously evaluate associations between five distinct patterns of conjoint symptom distress and functional impairment (symptom-functional states) and subjective caregiving burden, QOL, and depressive symptoms in a convenience sample of 215 family caregiver–patient dyads. Data were collected every 2 to 4 weeks over patients' last 6 months.Results
Caregivers of patients in the worst symptom-functional states (States 3–5) reported worse subjective caregiving burden and depressive symptoms than those in the best two states, but the three outcomes did not differ between caregivers of patients in State 3 and States 4–5. Caregivers of patients in State 5 endured worse subjective caregiving burden and QOL than those in State 4. Caregivers of patients in State 4 suffered worse subjective caregiving burden and depressive symptoms but comparable QOL to those in State 2.Conclusion
Patients' five distinct, conjoint symptom-functional states were significantly and differentially associated with their caregivers' worse subjective caregiving burden, QOL, and depressive symptoms while caring for patients over their last 6 months. 相似文献138.
139.
140.